4.0 Article

Relationship of weight and obesity with the risk of knee and hip arthroplasty for osteoarthritis across different levels of physical performance: a prospective cohort study

Journal

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
Volume 48, Issue 1, Pages 64-71

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/03009742.2018.1458148

Keywords

-

Categories

Funding

  1. National Health and Medical Research Council (NHMRC) [233200]
  2. Australian Government Department of Health and Ageing
  3. Abbott Australasia Pty Ltd
  4. Alphapharm Pty Ltd
  5. AstraZeneca
  6. Bristol-Myers Squibb
  7. City Health Centre Diabetes Service, Canberra
  8. Department of Health and Community Services, Northern Territory
  9. Department of Health and Human Services, Tasmania
  10. Department of Health, New South Wales
  11. Department of Health, Western Australia
  12. Department of Health, South Australia
  13. Department of Human Services, Victoria
  14. Diabetes Australia
  15. Diabetes Australia Northern Territory
  16. Eli Lilly Australia
  17. Estate of the Late Edward Wilson
  18. GlaxoSmithKline
  19. Jack Brockhoff Foundation
  20. Janssen-Cilag
  21. Kidney Health Australia
  22. Marian FH Flack Trust
  23. Menzies Research Institute, Merck Sharp Dohme
  24. Novartis Pharmaceuticals
  25. Novo Nordisk Pharmaceuticals
  26. Pfizer Pty Ltd, Pratt Foundation
  27. Queensland Health
  28. Roche Diagnostics Australia
  29. Royal Prince Alfred Hospital, Sydney
  30. Sanofi Aventis
  31. sanofi-synthelabo
  32. Victorian Government's OIS Program
  33. Arthritis Australia
  34. NHMRC [1142198, 1065464, 1063574]
  35. National Health and Medical Research Council of Australia [1065464, 1142198] Funding Source: NHMRC

Ask authors/readers for more resources

Objective: To examine the association between obesity and knee and hip arthroplasty for osteoarthritis across a range of physical performance. Method: The body mass index and physical performance (on the 36-item Short Form Health Survey) of 9135 Australian Diabetes, Obesity and Lifestyle Study participants were measured in 1999-2000. The incidence of knee and hip arthroplasty during 2002-2011 was determined by linking the cohort records to the Australian Orthopaedic Association National Joint Replacement Registry. Results: Over 9.1 +/- 2.3 years (mean +/- sd)) of follow-up, 317 participants had knee and 202 had hip arthroplasty for osteoarthritis. Using those with neither obesity nor significantly impaired physical performance as the reference group, participants with both obesity and significantly impaired physical performance had a higher knee arthroplasty risk [hazard ratio (HR) = 5.25, 95% confidence interval (CI) 3.85-7.14] than those with obesity alone (HR = 2.49, 95% CI 1.81-3.44) or impaired physical performance alone (HR = 2.19, 95% CI 1.59-3.02). Similar results were observed for hip arthroplasty (obesity and impaired physical performance: HR = 2.67, 95% CI 1.72-4.15; obesity alone: HR = 1.65, 95% CI 1.08-2.51; impaired physical performance alone: HR = 1.83, 95% CI 1.26-2.66). Among overweight/obese patients, 5 kg greater baseline weight increased the knee arthroplasty risk across all levels of physical performance, and hip arthroplasty risk in those with the highest level of physical performance. Conclusion: Although impaired physical performance is an independent risk factor for knee and hip arthroplasty, greater weight increased knee arthroplasty for overweight/obese participants at all levels of physical performance, but hip arthroplasty only in those with good physical performance. Targeting weight loss has the potential to reduce the risk of knee arthroplasty and improve patient outcomes, even in those with poor physical performance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available